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Sir- We would like to compliment Drs Bosio et al1 for the first reported prospective screening 
study for drug abuse in an Irish obstetric population. We would disagree, however, with the 
deduction that "drug abuse is not a serious problem among Dublin's pregnant population." 43 
cases of neonatal drug withdrawal were identified at our hospital between July 1996 and 
June 1997 and these babies had significant impact on facilities and staffing levels in our 
neonatal ICU.   
 
We recently anonymously screened the urine of 131 women who booked consecutively for 
antenatal care at the Coombe Women's Hospital, using a one-step immunoassay technique 
(Accusign; PBM, Princeton, New Jersey, USA). Further biochemical analysis of the samples 
was not performed. 5 samples tested positive for amphetamines; 2 for opiates and none for 
cocaine, yielding an overall detection rate of approximately 5%. Urine was not tested for 
other substances, e.g. methadone, cannabis, benzodiazepines or alcohol and therefore, our 
prevalence of "hard drugs" was approximately 3.8%. Again, this must be an underestimate of 
the true figure because of the limitations also cited in the author's paper.   
 
Surely we must give serious consideration to antenatal screening for drugs of abuse. As we 
know, drug history is unreliable, there is a significance prevalence of the condition, women 
are accustomed to providing urine samples regularly at antenatal visits and we have tests 
that are sensitive and specific and can provide immediate results. Diagnosis and early 
recognition of maternal drug abuse improves perinatal outcome by intensifying antenatal 
care2 and maternal treatment programmes are cost effective.3 Obviously, we would advocate 
proper structuring of perinatal facilities in Ireland for women who abuse drugs before 
screening could be implemented.   
 
In developed countries, it is accepted that in the public interest car drivers should be tested 
for alcohol excess. In sport, random drug testing is widely accepted. In many countries, the 
abuse of certain drugs is illegal. The individual rights of the woman must be considered but 
the impact of drug abuse during pregnancy on the newborn may be profound. We report our 
findings because we would like to provoke a debate as to whether screening for recreational 
drug abuse should be introduced universally in the maternity services in the interests of both 
our patients?   
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